To facilitate the evaluation of vaccines against bovine herpesvirus type 1 (BHV-1), a cotton rat model of intranasal (i.n.) BHV-1 infection was established. Cotton rat lung cells were similar to bovine cells in their ability to support BHV-1 replication in vitro. Furthermore, i.n. inoculation of cotton rats with BHV-1 resulted in pulmonary lesions comparable to BHV-1 infection in cattle. Using this model, the potential of i.n. and gastrointestinal (g.i.) immunization was examined with recombinant human adenoviruses expressing glycoprotein D (gD) of BHV-1 to induce protective immunity against BHV-1. The replication-competent virus (gD-dE3) was more efficient than the replication-defective virus (gD-dE1E3) in inducing gDspecific antibody in the serum and in the respiratory
Introduction
Bovine herpesvirus type 1 (BHV-1), a member of the subfamily Alphaherpesviridae, can cause a variety of diseases in cattle, including acute respiratory infections which render cattle susceptible to potentially fatal secondary bacterial pneumonia (Yates, 1982) . In order to develop new vaccination strategies, individual viral components, such as glycoprotein D (gD), that evoke effective protective immune responses to BHV-1 have been identified (Babiuk et al., 1987 ; van Drunen Littel van den Hurk et al., 1990) and reviewed . Since evaluation of vaccination strategies against BHV-1 in cattle is both costly and difficult, there is a need to develop a laboratory animal model for BHV-1 infection ; a rodent model would also be more feasible than cattle for investigating the mechanism of induction of mucosal immune responses. A candidate for developing such a model, the cotton rat (Sigmodon hispidus), has been used to study the pathogenesis of various human and animal respiratory viruses, including human adenovirus type 5 (hAd5) (Breker-Klassen et al., 1995 ; Mittal et al., 1995 ; Pacini et al., 1984 ; Porter et al., 1991 ; Prince et al., 1978 Prince et al., , 1993 .
Live hAd5 has been shown to be an excellent delivery system for vaccine antigens (Imler, 1995 ; Rosenthal et al., 1996) . Both replication-defective and replication-competent hAd5 have been used for insertion of foreign genes (Graham & Prevec, 1992) ; however, replication-defective viruses are often preferred to replication-competent vectors because of their greater safety. Adenoviruses deleted of the non-essential E3 early transcription region (dE3) remain replication-competent in permissive host cells, while deletion of the E1 region as well (dE1E3) results in a replication-defective virus. The replicationdefective virus can be propagated only in cells which express the E1 region proteins thus complementing the deficiency of the virus. Although unable to replicate in vivo, such dE1E3 viruses have been able to induce immunity to inserted gene products after systemic immunization (Eloit & Adam, 1995 ; Eloit et al., 1990 ; Fooks et al., 1995 ; Jacobs et al., 1994 ; Mittal et al., 1996 ; Ragot et al., 1993 ; Xiang et al., 1996) and sometimes following administration to the respiratory tract (Eloit et al., 1990 ; Gonin et al., 1996 ; Xiang et al., 1996) . Replication-competent dE3 adenoviruses, in contrast, have often proven effective not only following systemic immunization, but also after mucosal administration in the respiratory or alimentary tract (Baca-Estrada et al., 1995 ; Both et al., 1993 ; Breker-Klassen et al., 1995 ; Charlton et al., 1992 ; Chengalvala et al., 1997 ; Collins et al., 1990 ; Gallichan et al., 1993 ; Hsu et al., 1992 Hsu et al., , 1994 Lubeck et al., 1989 ; Morin et al., 1987 ; Prevec et al., 1989) ; reviewed by Rosenthal et al. (1996) .
Construction of replication-defective and replication-competent recombinant hAd5 carrying BHV-1 gD (gD-dE1E3 and gD-dE3, respectively) has recently been described (Mittal et al., 1996 ; van Drunen Littel van den Hurk et al., 1993) . Both of these viruses express gD in high quantities in vitro, and were able to induce humoral immunity to gD in cotton rats after systemic immunization (Mittal et al., 1996) . Systemic immunization alone with recombinant hAd5, however, usually does not induce effective mucosal immune responses and protection from respiratory virus challenge (Gallichan et al., 1993) .
In the present study, we established a model for BHV-1 infection by intranasal (i.n.) challenge in cotton rats. Using this model, we investigated the potential of mucosal immunization with recombinant adenoviruses via the i.n. and the gastrointestinal (g.i.) route for inducing protective immune responses against i.n. BHV-1 challenge. In addition, we compared the capability of gD-dE1E3 and gD-dE3 to stimulate gD-and adenovirus-specific immune responses in this model.
Methods
Animals. Inbred male and female cotton rats (S. hispidus), 3-5 months of age, seronegative to adenovirus and BHV-1, were obtained from barrier-maintained pathogen-free colonies at the Veterinary Infectious Disease Organization and Virion Systems, Inc. (Rockville, Maryland, USA). Animals were handled according to the guidelines of the Canadian Council on Animal Care and the University of Saskatchewan Committee on Animal Care and Supply.
Cells and viruses.
Cotton rat lung (CRL) cells were cultured and maintained as a stable cell line as previously described (Baca-Estrada et al., 1995) .
The Cooper strain of BHV-1 was obtained from the National Veterinary Services Laboratories (Ames, Iowa, USA). The virus was propagated in Madin-Darby bovine kidney (MDBK) cells using minimal essential medium (MEM) with Earle's salts (Gibco\BRL) supplemented with 10 % foetal bovine serum (FBS ; Gibco\BRL) and 2 mM -glutamine. The field isolate 108 strain of BHV-1 was obtained from the Animal Diseases Research Institute (Lethbridge, Alberta, Canada) and passaged twice in MDBK cells.
For inoculation of cotton rats, the supernatants of cultures of the 108 and Cooper strains were used. For ELISA, BHV-1 was purified by ultracentrifugation on discontinuous Na\K tartrate gradients as described (Misra et al., 1981) . Stocks of both strains of BHV-1 were titrated on MDBK and CRL cells and were stored in small aliquots at k70 mC.
The construction of recombinant hAd5 containing the BHV-1 gD gene in the E3 region utilizing an E3-deleted vector (gD-dE3) or in the E1 region utilizing an E1-E3-deleted vector (gD-dE1E3) has been described previously (Mittal et al., 1996 ; van Drunen Littel van den Hurk et al., 1993) . The recombinant viruses were propagated in 293 cells. For immunization, the viruses were purified by centrifugation in a discontinuous caesium chloride gradient. Virus titres were determined by plaque assay on 293 cells. For the in vitro assays, the wild-type hAd5 was purified by two rounds of continuous caesium chloride gradient centrifugation. Total protein content of each virus preparation was estimated by a Bio-Rad protein assay. The gD-dE1E3 and gD-dE3 virus preparations contained no more than 0n02 µg gD protein per 10) p.f.u. virus, estimated by a capture ELISA. UV-irradiated gD-dE1E3 and gDdE3 virus preparations do not induce gD-specific immunity in cotton rats (unpublished observations), indicating that gD present in the virus inoculum is insufficient to induce an immune response.
Virus infection and titration. BHV-1 was adsorbed onto CRL or MDBK cell monolayers for 1 h at 37 mC. Excess virus was removed by washing cells twice with PBS, followed by the addition of MEM supplemented with 2 % FBS (Gibco\BRL). At various time-points, cells and culture supernatants were harvested and frozen at k70 mC until all the samples could be processed simultaneously. Samples were titrated for BHV-1 by plaque assay on MDBK cells.
In vivo challenge and immunizations. Cotton rats were anaesthetized with nitrous oxide-halothane (MTC Pharmaceuticals) (1 : 2) during all immunizations and challenges. Blood samples were obtained by cardiac puncture. Animals were euthanized by halothane overdose.
For i.n. immunization (10) p.f.u. of purified adenovirus) and challenge (5i10( p.f.u. of BHV-1), viruses were administered in 50 µl volumes into the nares of cotton rats. For the intraduodenal immunization, 10) p.f.u. of adenovirus in 500 µl PBS, or PBS alone, was injected into the duodenum following its surgical exposure under aseptic conditions. The abdomen was then closed and the animals were housed under normal conditions. For oral immunization, 10) p.f.u. of adenovirus suspended in 500 µl of 0n4 M NaHCO $ was delivered into the stomach with a 20 gauge gavage needle. Before intraduodenal and oral immunization, cotton rats were starved overnight.
Preparation of trachea and lung extracts. After euthanasia, the trachea and right lung from each rat were aseptically removed and frozen in 1 ml MEM at k70 mC. When all samples were collected, they were thawed, weighed, homogenized (Polytron homogenizer ; Brinkman Industries, Rexdale, Canada) and centrifuged to remove debris. The resulting supernatants were assayed for the presence of BHV-1 and antibodies. In our experiments, antigen-specific antibody levels in lung and trachea extracts always correlated with those in lung and nasal washes, respectively (unpublished observation).
Histopathology and immunohistochemistry.
The left lung was fixed in 10 % neutral buffered formalin, processed routinely and embedded in paraffin wax. Sections were cut at 5 µm and stained with haematoxylin and eosin for histological evaluation.
Unstained sections of formalin-fixed lung from the same blocks were stained immunohistochemically using an avidin-biotin complex method (Haines & Chelack, 1991) adapted to a robotic system. The slides (three per animal) were incubated with a pool (3 : 1) of two monoclonal antibodies directed against BHV-1 gB (3F11) and gC (1H6) glycoproteins, respectively (gifts from V. Misra) or with normal mouse serum as negative control. Formalin-fixed bovine foetal liver from a case of natural BHV-1 infection was used as a positive control. Slides were treated with 3,3hdiaminobenzidine-H # O # solution as chromogen and counterstained with haematoxylin. A positive reaction consisted of brown deposits, indicating the presence of BHV-1 antigens.
A scoring system of 0 (normal), 1 (mild), 2 (moderate) and 3 (severe), based on the severity of lesions in the lower respiratory tract, was used for histological evaluation of the lungs. Lesions were graded separately for the bronchioles based on the development of intranuclear inclusion bodies, degree and extent of epithelial necrosis and inflammation, and for the alveoli based on intranuclear inclusion bodies, necrosis, neutrophils and macrophages in alveolar septa, and type II pneumocyte hyperplasia.
Preparation of lymphocytes from the spleen, bone marrow and lungs. Spleens and bone marrow were removed aseptically, chopped, then gently pushed through a plastic mesh with a 5 ml syringe plunger and washed with MEM. Erythrocytes were lysed by Trisbuffered 0n83 % NH % Cl and the resulting lymphocyte suspensions were washed with MEM. To obtain lymphocytes from the right lung, the tissue was cut into small pieces and incubated in complete medium : MEM supplemented with 10 % FBS (Hyclone Laboratories), 2 mM -glutamine, 1 mM sodium pyruvate, 100 µM non-essential amino acids, 10 mM HEPES buffer (Gibco\BRL), 50 µM 2-mercaptoethanol and 100 U\ml penicillin G, 100 µg\ml streptomycin solution (Sigma), with 150 U\ml collagenase A (Worthington) and 50 U\ml DNase I (Sigma) for 1 h, then pushed through a plastic mesh. The lung cell suspension was centrifuged through a discontinuous Percoll (Pharmacia) gradient, then washed with MEM. Cells were resuspended in complete medium and incubated for 1 h in a tissue culture flask to attach adherent cells. The non-adherent cell population was then resuspended and used in the ELISPOT assay.
Antigen-specific ELISPOT assay. An enzyme-linked immunospot (ELISPOT) assay was used to determine the levels of gD-and adenovirus-specific antibody secreting cells (ASC) in the spleen, bone marrow and lung. Nitrocellulose based, hydrophobic, 96-well microtitre plates (Polyfiltronics) were coated with purified gD (0n3 µg per well) or hAd5 (1 µg per well) in coating buffer (50 mM NaHCO $ \Na # CO $ pH 9n6) at 4 mC overnight. After washing with PBS under sterile conditions, plates were incubated with complete medium for 1 h at room temperature. Lymphocytes (0n1-1i10' cells per well) were then incubated in complete medium in the plates for 8 h at 37 mC. Following incubation, cells were removed by washing the plates with distilled water, then with PBS containing 0n05 % Tween-20 (Sigma ; PBS-T). To detect antigen-specific IgG, biotinylated anti-rat IgG (Zymed) in PBS containing 0n5 % BSA (Boehringer-Mannheim ; PBS-BSA) was incubated in the plates. Antigen-specific IgA spots were detected by incubating rabbit anti-rat IgA (a gift from B. Underdown, McMaster University Health Sciences Centre, Hamilton, Ontario, Canada) followed by biotinylated goat anti-rabbit antibody (Zymed). Plates were washed with PBS-T between each step. All plates were incubated with streptavidinalkaline phosphatase, followed by spot development with 5-bromo-4-chloro-3-indolyl phosphate (BCIP)-nitro blue tetrazolium (NBT) substrate. The numbers of spots in triplicate cultures were counted with the aid of a dissecting microscope.
ELISA. Antibody levels specific for BHV-1 and adenovirus in sera or in lung and trachea extracts were determined by ELISA. Immulon-2 microtitre plates (Dynatech) were coated with purified gD (0n05 µg per well), BHV-1 or hAd5 (0n5 µg per well) in coating buffer. The plates were washed with PBS-T between each step. All samples were serially diluted in PBS-BSA and incubated in the plates overnight at 4 mC. Antigenspecific IgG was detected by horse-radish peroxidase-conjugated goat anti-rat IgG (Zymed). Antigen-specific IgA was measured by rabbit antirat IgA, followed by incubation with horse-radish peroxidase-conjugated goat anti-rabbit IgG (Gibco\BRL). Colour was developed by using 2,2h-azino-di-(3-ethyl-benzthiazoline sulfonate) (ABTS ; Boehringer-Mannheim) as a substrate. The light absorbency of developed samples was determined at A %!& using a microplate reader (Bio-Rad model 3550). Antibody titres represent the log "! of the inverse of the highest dilution of samples the absorbency of which was higher than the sum of the mean background absorbency and three standard deviations. Antibody titres specific for gD were identical regardless of whether purified BHV-1 or gD was used for coating the ELISA plates. Statistical analysis of the data was performed using Student's t-test.
Serum neutralization assay. Doubling dilutions of heat-inactivated serum samples were mixed with 100 p.f.u. of BHV-1 and incubated for 1 h at 37 mC. The virus-sample mixture was then plated on confluent MDBK cells in 96-well tissue culture plates and incubated for 2 days. Serum neutralizing (SN) titre was defined as the log "! of the inverse of the highest dilution of serum that caused a 50 % reduction of the number of plaques relative to the virus control.
Results

Kinetics of BHV-1 replication in cotton rats
Before inoculation in vivo, we determined whether BHV-1 could replicate in CRL cells in vitro. The growth of BHV-1 in CRL cells was comparable to that observed in MDBK cells (Fig.  1) . In both cell lines, isolate 108 replicated to a slightly higher titre than the laboratory Cooper strain (Fig. 1) .
Since BHV-1 could replicate efficiently in CRL cells in vitro, we inoculated cotton rats i.n. with the two different strains of BHV-1 and monitored virus growth in the respiratory tract. Virus recovery from the trachea and lung showed increasing titres of the 108 strain of BHV-1, resulting in a peak between days 1 and 2 post-infection (p.i.) (Fig. 2) . From day 2 onwards, virus titres of both the Cooper and 108 strains declined and the virus was completely cleared by day 8 in all animals. The cotton rats did not show any apparent signs of disease or change in behaviour at any stage of the BHV-1 infection period. However, they developed cellular and humoral immune responses to BHV-1 glycoproteins by day 8 p.i. (data not shown).
Histopathological and immunohistochemical evaluation of BHV-1-infected cotton rat lungs
To demonstrate virus-induced cell damage arising from BHV-1 infection and replication in the cotton rat lung, sections of lung from infected cotton rats were examined histologically. The results of histological evaluation of cotton rat lungs infected with the Cooper and 108 strains of BHV-1 are summarized in Fig. 3 (a, b) . No lesions were seen in the lungs of rats killed at 6 h following infection. Randomly, rare intra- alveolar macrophages and indistinct intranuclear inclusion bodies in bronchiolar epithelial cells were seen on day 1 p.i. By day 2, rats infected with the BHV-1 108 strain exhibited multifocal moderate bronchiolitis with presence of intranuclear inclusion bodies in bronchiolar epithelial cells, epithelial cell necrosis and infiltration of neutrophils into the mucosa and lumen (Fig. 3 c) . Multifocal, moderate interstitial pneumonia with macrophage and neutrophil infiltration of alveolar septa, along with a few inclusion bodies in alveolar epithelial cells and occasional intra-luminal cells, was also seen (Fig. 3 d) . An inflammatory response, mild within the airways (one of three rats) and moderate in the alveoli (three of three rats) was present at day 4 p.i. Type II pneumocyte hyperplasia and macrophage infiltration of the septa were evident, but inclusion bodies were absent. By day 8, a mild peribronchiolar lymphocytic infiltration was present along with alveolar septal infiltration of macrophages, or macrophages and lymphocytes.
The Cooper strain was less pathogenic for the cotton rats than the 108 strain, producing only mild focal lesions. Lesions persisted through day 4 and waned by day 8.
To correlate histological changes with BHV-1 infection and replication, lung sections were examined by immunohistochemical staining for the presence of BHV-1 antigens. In the lungs of cotton rats infected with the Cooper strain, only a few cells, randomly distributed throughout the alveoli, stained positively for the BHV-1 antigens at 6 h. By day 1, in all three rats infected there were several small, positively staining foci of bronchiolar epithelial cells, and in one animal alveolar epithelial cells were also positive. Such foci indicating BHV-1 replication were moderately numerous by day 2, involving both bronchiolar and alveolar epithelium. They were also present in similar numbers and distribution on day 4, but were absent by day 8.
Lungs of cotton rats infected with the 108 strain did not contain any detectable BHV-1 antigens at 6 h p.i. Several to many moderately sized foci of positively staining cells within the bronchiolar and alveolar epithelial cell population were found at day 1. Staining was widespread with moderate to large-sized bronchiolar and alveolar positive foci by day 2 (Fig.  3 e, f) . Many moderately sized foci were still present on day 4 but were absent by day 8. Specific staining was generally cytoplasmic in distribution and corresponded for the most part with histological lesions.
Antibody response after immunization
Groups of cotton rats (three animals per group) were inoculated twice i.n., 3 weeks apart, with 10) p.f.u. of the gDdE1E3 or the gD-dE3 recombinant adenoviruses. Separate groups of cotton rats (four animals per group) were immunized with 10) p.f.u. of gD-dE1E3 or gD-dE3 by the intraduodenal route, and then boosted with a second dose of the same preparation orally 3 weeks later (g.i. immunization groups). Control animals were inoculated with PBS. Evans blue dye was
(e) (f) Fig. 3 . Histological changes and immunohistochemical staining in the lungs of cotton rats inoculated with BHV-1. Lungs were collected at various time-points after i.n. infection with 5i10 7 p.f.u. of Cooper or 108 strains and evaluated for histological lesions in the (a) bronchioli and (b) alveoli. Lesions were scored according to severity on a scale of 0 (normal) to 3 (severe). Each bar denotes a mean of scores for three animals at 6 h, days 1 and 4 p.i., and for two animals at days 2 and 8 p.i. Lesions (c, d) and immunohistochemical (IHC) staining (e, f) shown are at day 2 p.i. with the 108 strain. Note (c) epithelial necrosis and luminal debris in a bronchiole (bar, 10 µm) and (d) marked cellular infiltration of alveolar septa (bar, 40 µm). Inset : intranuclear inclusion body in a desquamated alveolar epithelial cell (bar, 5 µm). Positive IHC staining (arrows) was noted multifocally in (e) the bronchiolar epithelium (bar, 150 µm) and (f) the alveolar walls (bar, 150 µm).
used to confirm that the inoculum was restricted to the site of administration and did not spread to the peritoneum or the respiratory tract following intraduodenal or oral delivery.
To determine antigen-specific systemic humoral responses, serum antibody titres specific for gD and adenovirus were measured 3 weeks after the secondary immunization (Fig. 4) . Both gD-dE3 and gD-dE1E3 induced gD-specific IgG and IgA in the serum regardless of the route of administration. The gDdE3 virus, however, induced significantly higher levels of gDspecific IgG in the serum than did gD-dE1E3 (P 0n05). All four immunization regimens stimulated similar levels of adenovirus-specific IgG in the serum (data not shown).
To measure biological activity of the gD-specific serum antibody, BHV-1 SN titres were determined. Immunization by the i.n. or the g.i. routes with gD-dE3 induced a BHV-1 log "! SN titre of 1n5p0. In contrast, the gD-dE1E3 virus induced a log "! SN titre of 0n7p0n3 following i.n., and no detectable titre following g.i. immunization.
Antibody production in the respiratory tract
To determine the ability of the different immunization regimens to induce antigen-specific humoral immune responses in the respiratory tract, lung and trachea extracts were analysed for the presence of gD-and adenovirus-specific antibody. Immunization with the gD-dE3 vector induced significantly higher gD-specific IgA and IgG in the lung (P 0n001) and trachea (P 0n01) than immunization with the gD-dE1E3 virus and the PBS control (Fig. 4) . Titres of gD-specific IgG in the respiratory tract correlated with those in the serum, while the relative ratio of lung : serum gD-specific IgA compared to lung : serum IgG suggested that IgA was locally produced in the lung (Fig. 4) .
Protection of cotton rats against BHV-1 challenge
Since mucosal immunization with the recombinant adenoviruses induced immune responses in the serum and the respiratory tract, we assessed their ability to confer protection against BHV-1 challenge. Cotton rats were challenged with 5i10( p.f.u. of the 108 strain of BHV-1 i.n., 3 weeks after secondary immunization. Table 1 shows the results of BHV-1 recovery from the trachea and the lung 24 h after BHV-1 challenge. Immunization with the gD-dE3 vector i.n. resulted in complete reduction of BHV-1 titres in the lungs of two out of three animals (different from PBS controls, P 0n05) and partial reduction of BHV-1 titres in one animal. In addition, g.i. immunization with the gD-dE3 virus partially reduced BHV-1 titres in the respiratory tract of three out of four animals. In contrast, gD-dE1E3 induced a partial reduction in mean BHV-1 titres only in the trachea compared to the PBS control, regardless of the route of immunization.
Immunity and protection induced by i.n. administration of gD-dE3
In order to confirm protection against BHV-1 challenge and to further characterize the antigen-specific immunity induced by i.n. administration of gD-dE3, groups of cotton rats were inoculated twice i.n. with 10) p.f.u. of gD-dE3 (14 animals per group) or with PBS (12 animals per group), 3 weeks apart. Seven animals from each group were challenged with BHV-1 3 weeks after the second immunization, and the other animals were challenged 12 weeks after the second immunization.
gD-specific serum IgG and IgA levels at different timepoints following immunization are shown in Fig. 5 . Serum antibody specific for gD was induced by the primary immunization with gD-dE3 and its level increased slightly following the secondary immunization. Serum levels of gDspecific IgG and IgA (Fig. 5) and BHV-1 log "! SN titres of 1n6 were maintained during the 12-week period, as well as the levels of antigen-specific antibodies in lung extracts (data not shown). The kinetics of adenovirus-specific responses were similar to gD-specific antibody responses (data not shown). (4) and IgA () titres were measured by ELISA. Error bars represent the standard deviation of log 10 antibody titres for seven animals per group. Control animals maintained background levels of antibody during the study (not shown) equal to that of gD-dE3-immunized animals at day 0.
To determine whether antigen-specific ASC were maintained locally in the lung or in peripheral lymphoid tissues in the cotton rat, ELISPOT assays were performed 12 weeks following immunization. Both gD-and adenovirus-specific ASC were found in the lung, bone marrow and spleen of gDdE3-immunized animals ( Table 2 ). The number of ASC in the lung 12 weeks after immunization was similar to that in the lung of animals 3 weeks following immunization (data not shown).
To assess the protective ability of i.n. immunization with gD-dE3 against BHV-1 infection, lungs of cotton rats were Table 2 . Frequency of gD-and adenovirus-specific antibody-secreting cells in lymphocytes from different tissues of cotton rats immunized intransally with recombinant adenoviruses Cotton rats were inoculated intranasally twice, 3 weeks apart, with recombinant adenovirus gD-dE3 (seven animals) or PBS as a control (five animals). Twelve weeks after the secondary immunization all animals were challenged intranasally with BHV-1. Spleen, bone marrow and lungs were collected from animals 3 days after challenge examined for evidence of BHV-1 replication 3 days after challenge. Virus was isolated from lungs of control animals but not from immunized animals challenged at either 3 weeks or 12 weeks following the second immunization (Table 3) . Lungs of cotton rats in the control groups had lesions of a multifocal mild interstitial pneumonia with type II pneumocyte proliferation and infiltration of macrophages. Small foci positive for BHV-1 antigen were also demonstrated randomly, usually (but not invariably) associated with foci of interstitial pneumonia. In contrast, lungs from the two groups of immunized cotton rats did not have any lesions or BHV-1 replication foci, indicating significant protection following vaccination.
Discussion
Since vaccination-challenge studies are expensive in cattle, it is important to evaluate potential vaccine candidates in an experimental animal model. To establish the BHV-1 i.n. challenge model in cotton rats, we demonstrated that BHV-1 replicated in the respiratory tract of cotton rats without requiring prior adaptation of the virus. The histological lesions seen in the lung of each rat, namely necrotizing bronchiolitis with the presence of intranuclear inclusion bodies in epithelial cells, were consistent with lesions observed following BHV-1 infection in cattle (Jericho & Darcel, 1978) . Reviewing the evidence on pulmonary histopathological changes in cattle, Yates (1982) found the lesions to be highly variable and inconsistently present, both in natural and experimental infections. In the cotton rats, immunohistochemical staining confirmed that BHV-1 became established in the lung and was the cause of the changes seen, as specific virus staining was Table 3 . Effect of intranasal immunization with recombinant adenovirus on the protection of cotton rats against intranasal BHV-1 challenge Cotton rats (groups of seven or five) were inoculated intranasally twice, 3 weeks apart, with gD-dE3 or PBS as a control. Three or 12 weeks after the secondary immunization animals were challenged with BHV-1 intranasally. Three days post-challenge, lungs were removed and tested for BHV-1 replication (virus isolation and BHV-1-specific foci) and pathological changes (interstitial pneumonia) in the lungs
Weeks
Virus isolation following (log 10 p.f.u./g BHV-1-Interstitial immunization Immunization lung tissue) specific foci pneumonia
demonstrated in the lesions in the terminal bronchioles and alveoli. The normal behaviour and absence of clinical signs in the cotton rats indicated that while BHV-1 became established and replicated within the respiratory tract, the infection was mild and subclinical. It would be interesting to determine whether passage of the virus in cotton rats would enhance virulence, or whether virus infection would predispose animals to secondary bacterial infection as it does in cattle. Nevertheless, the fact that the BHV-1 infection in cotton rats mimics the disease in cattle in terms of pathological changes suggests that this may be a valid laboratory animal model for use in development and primary evaluation of new vaccination strategies against BHV-1. Our results show that the Cooper and 108 strains of BHV-1 differed in their ability to replicate both in CRL cells and in cotton rats. Lesion development was greater, viral antigen was more widespread and higher titres of BHV-1 were evident in the lungs of animals challenged with the 108 strain than with the Cooper strain. The more virulent nature of the 108 strain as compared to the Cooper strain in cattle has been previously suggested (unpublished observation), further supporting the similarity of the cotton rat model to bovine disease. Based on the observed differences between the two strains, we used the 108 strain for our subsequent challenge experiments.
We demonstrated the potential of the cotton rat model for the evaluation of recombinant hAd5 vectors expressing gD of BHV-1. Since no other laboratory rodent has been shown to support the replication of both hAd5 and BHV-1, the cotton rat has become the most appropriate model for comparing replication-defective and replication-competent viruses with regard to their effectiveness in inducing immunity to gD and conferring protection against BHV-1 challenge. Systemic immunization studies comparing replication-defective and replication-competent recombinant adenoviruses have suggested that the two types of vector may be equally effective for the induction of antigen-specific immune responses (Eloit & Adam, 1995 ; Mittal et al., 1996) . Eloit & Adam (1995) observed, however, that immunization with a replicationdefective adenovirus expressing gD of pseudorabies virus (PRV) induced protection of cotton rats and mice against PRV challenge only at much higher doses of immunization than with a replication-competent vector. Furthermore, oral immunization with replication-competent adenovirus expressing rabies glycoprotein induced antibody responses and partial protection against experimental rabies infection in mice, while replication-defective virus did not (Prevec et al., 1990 ; Xiang et al., 1996) . However, no studies have directly compared the efficacy of replication-defective and replication-competent adenoviruses expressing the same foreign gene in inducing mucosal and systemic immunity following mucosal administration.
In the present study, we found that i.n. administration of the replication-competent gD-dE3 virus induced gD-specific antibody responses and resulted in complete protection of the lungs of most cotton rats against i.n. challenge with BHV-1. The replication-defective gD-dE1E3 virus, however, induced significantly lower levels of antibody than gD-dE3 and resulted in only a partial reduction of BHV-1 titres compared to controls. Previous experiments have shown gD-dE1E3 and gD-dE3 to be similar in their ability to induce immune response and partial protection to BHV-1 challenge following intradermal administration (Mittal et al., 1996) . These observations, together with the results of the present study, suggest that the route of immunization is crucial when assessing the efficacy of recombinant adenoviruses as vaccine vectors. Intradermal inoculation with the replication-defective virus may have allowed for a more efficient expression of gD in the skin, and possibly other tissues, than mucosal administration. Alternatively, the higher level of gD-specific antibody responses induced by gD-dE3 compared to gD-dE1E3 following mucosal administration may be the result of a more invasive infection by gD-dE3 than gD-dE1E3, allowing for higher gD-expression in the mucosa-associated lymphoid tissue and in draining lymph nodes following mucosal infection with gD-dE3. Finally, the ability of the gD-dE3 virus to produce larger amounts of gD than the gD-dE1E3 virus during the first day of infection of CRL cells in vitro (unpublished observation) may influence the immune responses induced.
Induction of mucosal immunity may be crucial in protecting a host from a respiratory virus infection. Mucosal antibody, such as secretory IgA, has usually been found to correlate with resistance to such infections (Kraehenbuhl & Neutra, 1994 ; Murphy, 1994) . Our results are consistent with reports in the literature : the highest levels of IgA in trachea and lung extracts correlated with the best protection against BHV-1 challenge in animals immunized i.n. with gD-dE3 (Fig. 4) . Furthermore, higher levels of IgA in the respiratory tract compared to those in the serum, and the presence of ASC in the lung, suggest that antibody was locally produced in the lung.
Interestingly, antigen-specific ASC in the lung were present at similar levels at 12 weeks following immunization as at 3 weeks following immunization. Serum antibody titres were also maintained (Fig. 5) and ASC in the bone marrow (Table 3) were detected. Others have found that long term humoral response and even protection from mucosal virus challenge could be achieved following live virus administration to the mucosa (Gallichan et al., 1993 ; McNeal & Ward, 1995) . This may be due to ASC maintained for the lifetime of rodents in the bone marrow and in the draining mediastinal lymph nodes following respiratory virus infection (Hyland et al., 1994) . These observations are interesting because mucosal virus infections usually stimulate immunity of shorter duration than systemic infections (Slifka & Ahmed, 1996) . Certain viruses, such as adenoviruses, may be unique in that they can induce long-term mucosal and systemic immune responses following mucosal administration. This may be associated with their ability to spread systemically (Huard et al., 1995 ; Oualikene et al., 1994) even though they primarily infect mucosal tissues.
Similarly to i.n. immunization, g.i. administration of gDdE3 could also induce gD-specific antibody in the serum and in lung and tracheal extracts. In addition, intraduodenal-oral administration of gD-dE3 induced ASC in the lung (unpublished observation). Only partial protection was observed, however, against BHV-1 challenge in these animals. This finding is in accordance with other reports showing that i.n. delivery of live virus is often more effective than gastroenteric administration (Collins et al., 1990 ; Kanesaki et al., 1991 ; Meitin et al., 1994) . Perhaps local induction of antigen-specific immune responses in the lung is necessary to achieve complete protection.
Observations that gastroenteric immunization with live viruses can induce protective immunity in the respiratory tract are thought to support the concept of a common mucosal immune system . Antibody induced in
